Len Pattenden
Chief Operating Officer @Innovaavector
Signup · Get unlimited contacts
WORK HISTORY
Chief Operating Officer @Innovaavector
EDUCATION
QUT (Queensland University of Technology)
Doctor of Philosophy (PhD), Pharmaceutics and Drug Design
SKILLS
ABOUT LEN PATTENDEN
Biopharma professional experienced in new biological drug development from onset to commercial. Track record in manufacturing, including first-in-man/first-in-class cell and gene therapies, viral vectors, biologics, and monoclonal antibodies. Leveraging subject matter expertise to drive innovation and process development operations. From exploratory research to biomolecule process development to production, including CMC management, technical transfers, and Regulatory document generation. Biomolecule experience includes DNA, RNA, peptides, biomembranes, monoclonal antibodies, enzymes, viral vectors and cell therapies. Demonstrated ability to complete regulatory and licensing requirements, including MHRA, FDA, GMO, and HSE guidelines. Career ExperienceFondazione Telethon, Italy. 2024 - PresentHead of CMCOversight of all CMC activities for Commercial and Early stage programs. Oversee all CDMO activities. Hold direct oversight of end-to-end CMC operations. Responsible for Operational Excellence.InnovAAVector, Naples, Italy. 2025 - PresentChief Operating Officer (COO)Hold direct oversight of end-to-end business operations supporting PhI - CDMO activities. CMC Biopharma Ltd, London, UK 2021 – PresentFounder / Owner / Chief Executive Officer (CEO) Supporting International PhI to commercial programs, CMC Training and Pharma Discovery.Ascend Gene & Cell Therapies Ltd, London, UK 2021 – 2023Co-Founder / Chief Operating Officer (COO)Cancer Research UK (CRUK), London, UK 2018 – 2021Head of Biotherapeutic Development & Drug SupplyLicense holder (MIA (IMP) 21106). Managed GMP, leader on all operations from project introduction, through process development, into manufacturing and to clinical trial. Adaptimmune Therapeutics PLC, UK 2018Process Development Group LeaderViral Vector Upstream Team, all workflows and reporting technical transfer operations to manufacturing personnel. manage, stakeholders, and strategic partners, including R&D, QA, QC, Catapult, CMC, MS & T, and Regulatory Affairs.Lonza Pharma & Biotech, UK 2018Senior Group Leader, R&D IP creation, manufacturing process development, model scaling, and new media manufacturing in support of next-generation CHO platform engineering and perfusion systems. INVISTA, UK 2016 – 2018Technical Capability LeaderTechnical Director and Department Head for process development and analytical sections. CSL, AU 2012 – 2016PD SME for upstream. Key member of a Process Development Expert Team (PDET). Supported all upstream CMC operations for new products and market-access drugs.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.